Restoring Insulin Secretion Pediatric Medication Study

Trial Profile

Restoring Insulin Secretion Pediatric Medication Study

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2017

At a glance

  • Drugs Insulin glargine (Primary) ; Metformin (Primary)
  • Indications Prediabetic-state; Type 2 diabetes mellitus
  • Focus Biomarker; Therapeutic Use
  • Acronyms RISE Peds
  • Most Recent Events

    • 05 Apr 2016 Planned End Date changed from 1 Aug 2017 to 1 Jan 2018 as reported by
    • 05 Apr 2016 Status changed from recruiting to active, no longer recruiting as reported by
    • 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top